Assertio Holdings is a health services company that focuses on restoring lives through various therapeutic products and solutions. The description includes self-described elements.

Assertio Holdings

Assertio | 8,105 followers on LinkedIn. Restoring Lives by Advancing Patient Care  | Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. 

Ticker symbol:
ASRT

Jeffrey Bennish, FACHE

Senior Vice President Human Resources and Administration at Assertio

Molly Dir

Gross to Net Expertise | US Managed Markets Analytics Leader | Pharmaceutical Industry

Jill Ngo, MBA

Sr. Vice President of Operations at Assertio

Bill Iskos

Assertio

Today is International LGS Awareness Day™! 💜 Join us today and all month long during #EpilepsyAwarenessMonth , as we shine a light on Lennox-Gastaut Syndrome (LGS), a rare and severe form of epilepsy. LGS often begins in early childhood and is characterized by multiple types of seizures, learning delays, and developmental challenges. By spreading awareness, we can support families affected by LGS and work towards better treatments and understanding. #LennoxGastautSyndrome #LGSawareness #Epilepsy #RareDisease Thank You to our International LGS Awareness Day Partners: Jazz Pharmaceuticals, Longboard Pharmaceuticals, UCB, Takeda Pharmaceuticals, Neurelis, NeuroPace, and Assertio Pharmaceuticals.

Lennox-Gastaut Syndrome (LGS) Foundation

Lennox-Gastaut Syndrome (LGS) Foundation Syndrome (LGS) Foundation is here to help. #LennoxGastautSyndrome #EpilepsyAwareness #LGSAwareness #EpilepsyAwarenessMonth

Dr. Tracy Dixon-Salazar

Epilepsy Alliance America is proud to be a national partner of Epilepsy Awareness Day presented by Sofie's Journey at Disneyland, the largest gathering of epilepsy patients and physicians on Earth! We're packing our dance shoes for the trip because we're hosting a fun family dance party and we hope you'll join us! Registration info for the expo and the dance party below! 🔗 Registration for Epilepsy Awareness Day at Disneyland Educational Expo: https://lnkd.in/g-SSzurv 🔗 Registration for Family Dance Party: https://lnkd.in/gDjWQ3rN

Epilepsy Alliance America

Epilepsy Alliance America is proud to be a National Partner of Epilepsy Awareness Day presented by Sofie's Journey at Disneyland and a proud sponsor of the family dance party! 🪩 Our volunteers, sponsors, and special guests are excited to welcome all Epilepsy Awareness Day at Disneyland families to an evening of food, games, and dancing in a safe and sensory-friendly environment. Register using the link or QR code: https://lnkd.in/gDjWQ3rN

Epilepsy Alliance America is proud to be a National Partner of Epilepsy Awareness Day presented by Sofie's Journey at Disneyland. We are one month away from attending the largest gathering of epilepsy physicians and patients on earth, coming together to raise awareness, share knowledge, and empower families. Registration is free for the educational expo. Find more information and sign up via the link! https://lnkd.in/gwcWHZ8m

Earlier this year, I reached out to Dr. Tracy Dixon-Salazar to learn more and write about her story with her daughter, Savannah, and how she created the Lennox-Gastaut Syndrome (LGS) Foundation . Tracy is passionate about helping her daughter and other families who live with LGS. It's a rare, devastating and severe form of epilepsy that begins in early childhood. Tragically, Savannah has experienced over 40,000 seizures in her life and Tracy has done all she can to understand the disease and find more effective ways of controlling seizures and improving quality of life. Read on to learn more about her accomplishments, connecting with and helping other families and facilitating epilepsy research with the LGS Foundation. 💜 #epilepsy #seizures #LGS #lennoxgastautsyndrome #LGSFoundation #epilepsywarriors #epilepsycommunity #epilepsyeducation #epilepsyresearch #LGSresearch #epilepsysupport #epilepsyheroes

Amber Kaiser

🌟2024 LGS Awareness Apparel is now available!!🌟 By ordering and wearing your official LGS Awareness Apparel, you're helping raise awareness of Lennox-Gastaut Syndrome around International LGS Awareness Day and Epilepsy Awareness Month! 🌍💜 Let's stand together, wear our support, and shine a light on LGS. Every purchase makes a difference! 🔗 Order now at https://lnkd.in/eJiyeVVY #LennoxGastautSyndrome #LGSAwareness #EpilepsyAwarenessMonth

💚 9th International Family & Professional Conference 💜 "Our LGS Conference is more than an event - it's a chance for us to strengthen bonds, share insights, and grow together as a community. Its success lies in the incredible spirit of our families, researchers, and partners coming together to learn, share, and inspire one another." - Tracy Dixon-Salazar, PhD

Vince Milano

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

HSTS

Google Font API

Google Analytics

DNSSEC

Content Delivery Network

President and Chief Executive Officer

Daniel Peisert

Senior Vice President and Chief Financial Officer

Paul Schwichtenberg

Senior Vice President, General Counsel

Sam Schlessinger

Sr. Vice President of Operations

Sr. Vice President, Commercial Operations

Jeff Christensen

Vice President, Business Development and Commercial Analytics

Vanessa Fox

Senior Director Regulatory Affairs

Clorey Toombs

Finance and Administration

Edilberto Ramos

Director, US Marketing

Erin Bouldin

National Sales Director, Hospital

Jeffrey Bennish

G. Steven Burrill

Louis Lavigne

Howard Franklin

Senior Vice President

Matthew Gosling

Senior Vice President and General Counsel

Brendan O'Grady

Companies That Exited in 2018 (Top 10K)

Medical Public Companies With More Than $50M in Revenue

Pharmaceutical Public Companies With More Than 50 Employees

Biotechnology Companies With Less Than $1B in Revenue (Top 10K)

Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the management of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.

Post-IPO Equity - Assertio

Post-IPO Debt - Assertio

Lake Forest

Illinois

United States

North America

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Activist investor calls for board shakeup at Assertio, threatens proxy contest

H.C. Wainwright starts Assertio at buy, calls stock underrated, overlooked

Assertio Holdings (NASDAQ:ASRT) adds US$14m to market cap in the past 7 days, though investors from five years ago are still down 89%

Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed

news impact assignment basic	general
public peers	general	Nov 10, 2024 11:36 PM	10ffaf01
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 10, 2024 11:36 PM	8f7de8d1
crunchbase trigger	general	Nov 10, 2024 11:36 PM	83c56a6b
crunchbase profile	general	Nov 11, 2024 6:55 AM	b6efb659
li profile	general	Nov 10, 2024 11:36 PM	9e010a16
translate crunchbase fundingrounds	general	Nov 11, 2024 7:38 AM	75f12a45
peers	general	Nov 10, 2024 11:36 PM	a7237a4b
news basic	general	Nov 10, 2024 11:36 PM	80badb7d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ASSERTIOTX

Assertio Holdings